Report Detail
Global Sickle Cell Anemia Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3290312 |
- 09 April, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
The classification of Sickle Cell Anemia Therapeutics includes Blood Transfusion, Pharmacotherapy and Bone Marrow Transplant, and the proportion of Blood Transfusion in 2017 is about 45%, and the proportion of Bone Marrow Transplant in 2017 is about 35%.
Sickle Cell Anemia Therapeutics is widely used for child and adult. The most proportion of Sickle Cell Anemia Therapeutics is for child, and the revenue share in 2017 is about 78%.
America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following America, Europe is the second largest consumption place with the consumption market share of 27%.
In 2018, the global Sickle Cell Anemia Therapeutics market size was 2170 million US$ and it is expected to reach 4500 million US$ by the end of 2025, with a CAGR of 11.0% during 2019-2025.
This report focuses on the global Sickle Cell Anemia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sickle Cell Anemia Therapeutics development in United States, Europe and China.
The key players covered in this study
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Market segment by Type, the product can be split into
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Market segment by Application, split into
Child
Adult
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Sickle Cell Anemia Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Sickle Cell Anemia Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Sickle Cell Anemia Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Blood Transfusion
- 1.4.3 Pharmacotherapy
- 1.4.4 Bone Marrow Transplant
- 1.5 Market by Application
- 1.5.1 Global Sickle Cell Anemia Therapeutics Market Share by Application (2014-2025)
- 1.5.2 Child
- 1.5.3 Adult
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Sickle Cell Anemia Therapeutics Market Size
- 2.2 Sickle Cell Anemia Therapeutics Growth Trends by Regions
- 2.2.1 Sickle Cell Anemia Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 Sickle Cell Anemia Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Sickle Cell Anemia Therapeutics Market Size by Manufacturers
- 3.1.1 Global Sickle Cell Anemia Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Sickle Cell Anemia Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Sickle Cell Anemia Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Sickle Cell Anemia Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Sickle Cell Anemia Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Sickle Cell Anemia Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Sickle Cell Anemia Therapeutics Market Size (2014-2019)
- 5.2 Sickle Cell Anemia Therapeutics Key Players in United States
- 5.3 United States Sickle Cell Anemia Therapeutics Market Size by Type
- 5.4 United States Sickle Cell Anemia Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Sickle Cell Anemia Therapeutics Market Size (2014-2019)
- 6.2 Sickle Cell Anemia Therapeutics Key Players in Europe
- 6.3 Europe Sickle Cell Anemia Therapeutics Market Size by Type
- 6.4 Europe Sickle Cell Anemia Therapeutics Market Size by Application
7 China
- 7.1 China Sickle Cell Anemia Therapeutics Market Size (2014-2019)
- 7.2 Sickle Cell Anemia Therapeutics Key Players in China
- 7.3 China Sickle Cell Anemia Therapeutics Market Size by Type
- 7.4 China Sickle Cell Anemia Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Sickle Cell Anemia Therapeutics Market Size (2014-2019)
- 8.2 Sickle Cell Anemia Therapeutics Key Players in Japan
- 8.3 Japan Sickle Cell Anemia Therapeutics Market Size by Type
- 8.4 Japan Sickle Cell Anemia Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Sickle Cell Anemia Therapeutics Market Size (2014-2019)
- 9.2 Sickle Cell Anemia Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Sickle Cell Anemia Therapeutics Market Size by Type
- 9.4 Southeast Asia Sickle Cell Anemia Therapeutics Market Size by Application
10 India
- 10.1 India Sickle Cell Anemia Therapeutics Market Size (2014-2019)
- 10.2 Sickle Cell Anemia Therapeutics Key Players in India
- 10.3 India Sickle Cell Anemia Therapeutics Market Size by Type
- 10.4 India Sickle Cell Anemia Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Sickle Cell Anemia Therapeutics Market Size (2014-2019)
- 11.2 Sickle Cell Anemia Therapeutics Key Players in Central & South America
- 11.3 Central & South America Sickle Cell Anemia Therapeutics Market Size by Type
- 11.4 Central & South America Sickle Cell Anemia Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Emmaus Medical
- 12.1.1 Emmaus Medical Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Sickle Cell Anemia Therapeutics Introduction
- 12.1.4 Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.1.5 Emmaus Medical Recent Development
- 12.2 Addmedica
- 12.2.1 Addmedica Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Sickle Cell Anemia Therapeutics Introduction
- 12.2.4 Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.2.5 Addmedica Recent Development
- 12.3 Gamida Cell
- 12.3.1 Gamida Cell Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Sickle Cell Anemia Therapeutics Introduction
- 12.3.4 Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.3.5 Gamida Cell Recent Development
- 12.4 GlycoMimetics
- 12.4.1 GlycoMimetics Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Sickle Cell Anemia Therapeutics Introduction
- 12.4.4 GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.4.5 GlycoMimetics Recent Development
- 12.5 Pfizer
- 12.5.1 Pfizer Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Sickle Cell Anemia Therapeutics Introduction
- 12.5.4 Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.5.5 Pfizer Recent Development
- 12.6 Novartis
- 12.6.1 Novartis Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Sickle Cell Anemia Therapeutics Introduction
- 12.6.4 Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.6.5 Novartis Recent Development
- 12.7 Global Blood Therapeutics
- 12.7.1 Global Blood Therapeutics Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Sickle Cell Anemia Therapeutics Introduction
- 12.7.4 Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.7.5 Global Blood Therapeutics Recent Development
- 12.8 Micelle BioPharma
- 12.8.1 Micelle BioPharma Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Sickle Cell Anemia Therapeutics Introduction
- 12.8.4 Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.8.5 Micelle BioPharma Recent Development
- 12.9 Bluebird Bio
- 12.9.1 Bluebird Bio Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Sickle Cell Anemia Therapeutics Introduction
- 12.9.4 Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.9.5 Bluebird Bio Recent Development
- 12.10 Prolong Pharmaceuticals
- 12.10.1 Prolong Pharmaceuticals Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Sickle Cell Anemia Therapeutics Introduction
- 12.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2014-2019)
- 12.10.5 Prolong Pharmaceuticals Recent Development
- 12.11 Modus Therapeutics
- 12.12 Sangamo Biosciences
- 12.13 Bioverativ
- 12.14 Imara
- 12.15 Ironwood Pharmaceuticals
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Sickle Cell Anemia Therapeutics . Industry analysis & Market Report on Sickle Cell Anemia Therapeutics is a syndicated market report, published as Global Sickle Cell Anemia Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Sickle Cell Anemia Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
